Christina M. Ackermann
Overview
Christina M. Ackermann received an average of $4M in total compensation, including $610K in salary, at Valeant Pharmaceuticals International from 2016 to 2021.
2021Valeant Pharmaceuticals InternationalExecutive Vice President, General Counsel and Head of Commercial Operations
2020Valeant Pharmaceuticals InternationalExecutive Vice President, General Counsel and Head of Commercial Operations
2019Valeant Pharmaceuticals InternationalExecutive Vice President, General Counsel and Head of Commercial Operations
2018Valeant Pharmaceuticals InternationalExecutive Vice President and General Counsel
2017Valeant Pharmaceuticals InternationalExecutive Vice President and General Counsel
2016Valeant Pharmaceuticals InternationalExecutive Vice President and General Counsel
Source: SEC filings on May 2, 2022, March 18, 2019, and March 21, 2018.
Related executives
We found 27 more executives who work or worked at Valeant Pharmaceuticals International.
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
Sam Eldessouky
Valeant Pharmaceuticals International
Chief Financial Officer
Robert Spurr
Valeant Pharmaceuticals International
President, U.S. Pharma Business
Joseph Gordon
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
William Humphries
Valeant Pharmaceuticals International
Group Chairman
J Pearson
Valeant Pharmaceuticals International